Quarterly report pursuant to Section 13 or 15(d)

Clinical Trial and Sponsored Research Agreements (License Agreements) (Details)

v3.22.2.2
Clinical Trial and Sponsored Research Agreements (License Agreements) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Clinical Trial and Sponsored Research Agreements        
Research and development for licenses acquired $ 40 $ 630 $ 40 $ 1,630